Wells Fargo’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
JT
Wells Fargo's UTHR Position: Q2 2026 in Review
Wells Fargo reduced its United Therapeutics (UTHR) stake by 3.7% in Q2 2026, selling an estimated $1.6M and leaving 74,303 shares worth $40.3M. The position accounts for 0.01% of the portfolio, ranked #1179.
Wells Fargo first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $110M in Q4 2017. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Wells Fargo held 74,303 shares of United Therapeutics worth $40.3M as of Q2 2026.
- Wells Fargo sold 2,835 United Therapeutics shares in Q2 2026, an estimated $1.6M.
- United Therapeutics made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #1179 holding.
- Wells Fargo first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's United Therapeutics position peaked at $110M in Q4 2017.
- 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.